|
Volumn 1, Issue 4, 2002, Pages
|
Antiangiogenic agents.
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
CYCLOOXYGENASE 2;
ENZYME INHIBITOR;
EPIDERMAL GROWTH FACTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ISOENZYME;
MATRIX METALLOPROTEINASE;
MEMBRANE PROTEIN;
PROSTAGLANDIN SYNTHASE;
PTGS2 PROTEIN, HUMAN;
CLINICAL TRIAL;
DRUG ANTAGONISM;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
NEOVASCULARIZATION (PATHOLOGY);
REVIEW;
VASCULARIZATION;
ANGIOGENESIS INHIBITORS;
ANTINEOPLASTIC AGENTS;
CARCINOMA, NON-SMALL-CELL LUNG;
CLINICAL TRIALS;
CYCLOOXYGENASE 2;
ENZYME INHIBITORS;
EPIDERMAL GROWTH FACTOR;
HUMANS;
ISOENZYMES;
LUNG NEOPLASMS;
MATRIX METALLOPROTEINASES;
MEMBRANE PROTEINS;
NEOVASCULARIZATION, PATHOLOGIC;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
RECEPTOR, ERBB-2;
|
EID: 0036654242
PISSN: None
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (1)
|
References (40)
|